Effective 1 de outubro, 2019, Cardiac Hemodynamic Monitoring using thoracic electrical bioimpedance will no longer require prior authorization for BlueCHiP for Medicare. There is no change to coverage for commercial products, or other methods referenced in the policy. Please see the full text of this policy here.